Disulfide bond cleavage of human fibrinogen by cis-diamminedichloroplatinum(II). 1992

N Ohta, and T Yotsuyanagi, and K Ikeda
Faculty of Pharmaceutical Sciences, Nagoya City University, Japan.

Disulfide bridges in fibrinogen (Fbg) were cleaved by cis-diamminedichloroplatinum(II) (cis-DDP). Incubation with 120 molar excess of cis-DDP at pH 7.4 and 37 degrees C in the presence of EDTA resulted in cleavage of seven disulfide bridges out of 29. In the presence of calcium, however, the number of cleavages were reduced to four. The result indicates that calcium, which has three high affinity sites on Fbg, protects disulfide bridges from the rupture. Thrombin clottability was examined by turbidity measurement. The cis-DDP treated Fbg was shown to give a decreased fiber thickness. As the cleavage proceeded, the clotting ability of Fbg decreased.

UI MeSH Term Description Entries
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

N Ohta, and T Yotsuyanagi, and K Ikeda
August 2005, Inorganic chemistry,
N Ohta, and T Yotsuyanagi, and K Ikeda
October 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
N Ohta, and T Yotsuyanagi, and K Ikeda
December 1992, General physiology and biophysics,
N Ohta, and T Yotsuyanagi, and K Ikeda
March 1979, Cancer treatment reviews,
N Ohta, and T Yotsuyanagi, and K Ikeda
December 1984, Japanese journal of clinical oncology,
N Ohta, and T Yotsuyanagi, and K Ikeda
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
N Ohta, and T Yotsuyanagi, and K Ikeda
January 1980, Cancer treatment reports,
N Ohta, and T Yotsuyanagi, and K Ikeda
January 1982, The Netherlands journal of medicine,
N Ohta, and T Yotsuyanagi, and K Ikeda
January 1982, The Netherlands journal of medicine,
Copied contents to your clipboard!